Peptic Ulcer - Pipeline Insight, 2021

Publisher Name :
Date: 12-Oct-2021
No. of pages: 60
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's, "Peptic Ulcer - Pipeline Insight, 2021," report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Peptic Ulcer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Geography Covered

- Global coverage

Peptic Ulcer Understanding

Peptic Ulcer: Overview

A peptic ulcer is an open sore or raw area in the lining of the stomach or intestine. There are two types of peptic ulcers: Gastric ulcer -- occurs in the stomach and Duodenal ulcer -- occurs in the first part of the small intestine. Normally, the lining of the stomach and small intestines can protect itself against strong stomach acids. Most ulcers occur in the first layer of the inner lining. A hole in the stomach or duodenum is called a perforation. This is a medical emergency. The most common cause of ulcers is infection of the stomach by bacteria called Helicobacter pylori (H pylori). Most people with peptic ulcers have these bacteria living in their digestive tract. Yet, many people who have these bacteria in their stomach do not develop an ulcer.

"Peptic Ulcer - Pipeline Insight, 2021" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Peptic Ulcer pipeline landscape is provided which includes the disease overview and Peptic Ulcer treatment guidelines. The assessment part of the report embraces, in depth Peptic Ulcer commercial assessment and clinical assessment of the pipeline products under development. In the report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Peptic Ulcer collaborations, licensing, mergers and acquisition, funding, designations and other product related details.

Report Highlights

- The companies and academics are working to assess challenges and seek opportunities that could influence Peptic Ulcer R&D. The therapies under development are focused on novel approaches to treat/improve Peptic Ulcer.

Peptic Ulcer Emerging Drugs Chapters

This segment of the Peptic Ulcer report encloses its detailed analysis of various drugs in different stages of clinical development, including phase II, I, preclinical and Discovery. It also helps to understand clinical trial details, expressive pharmacological action, agreements and collaborations, and the latest news and press releases.

Peptic Ulcer Emerging Drugs

- Fexuprazan: Daewoong Pharmaceutical

Fexuprazan is a novel potassium-competitive acid blocker (P-CAB) developed by Daewoong, which reversibly blocks the proton pump that secretes gastric acids located in the cannalicular membrane. It is a next-generation of proton pump inhibitors (PPI), which are widely used for gastroesophageal reflux disease (GERD). The drug is currently in phase III stage of clinical trial evaluation to treat peptic ulcers.

- KFP-H008: Jiangsu Carephar pharmaceuticals

KFP-H008 is a Potassium-competitive acid blocker being developed by Jiangsu Carephar pharmaceuticals. Currently, it is in Phase III stage of clinical trial evaluation to treat Duodenal ulcer.

Further product details are provided in the report……..

Peptic Ulcer: Therapeutic Assessment

This segment of the report provides insights about the different Peptic Ulcer drugs segregated based on following parameters that define the scope of the report, such as:

- Major Players in Peptic Ulcer

There are approx. 8+ key companies which are developing the therapies for Peptic Ulcer. The companies which have their Peptic Ulcer drug candidates in the most advanced stage, i.e. phase III include, Daewoong Pharmaceutical.

- Phases

DelveInsight's report covers around 8+ products under different phases of clinical development like

- Late stage products (Phase III)

- Mid-stage products (Phase II)

- Early-stage product (Phase I) along with the details of

- Pre-clinical and Discovery stage candidates

- Discontinued & Inactive candidates

- Route of Administration

Peptic Ulcer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

- Oral

- Parenteral

- intravenous

- Subcutaneous

- Topical.

- Molecule Type

Products have been categorized under various Molecule types such as

- Monoclonal Antibody

- Peptides

- Polymer

- Small molecule

- Gene therapy

- Product Type

Drugs have been categorized under various product types like Mono, Combination and Mono/Combination.

Peptic Ulcer: Pipeline Development Activities

The report provides insights into different therapeutic candidates in phase II, I, preclinical and discovery stage. It also analyses Peptic Ulcer therapeutic drugs key players involved in developing key drugs.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing along with a thorough therapeutic assessment of emerging Peptic Ulcer drugs.

Peptic Ulcer Report Insights

- Peptic Ulcer Pipeline Analysis

- Therapeutic Assessment

- Unmet Needs

- Impact of Drugs

Peptic Ulcer Report Assessment

- Pipeline Product Profiles

- Therapeutic Assessment

- Pipeline Assessment

- Inactive drugs assessment

- Unmet Needs

Key Questions

Current Treatment Scenario and Emerging Therapies:

- How many companies are developing Peptic Ulcer drugs?

- How many Peptic Ulcer drugs are developed by each company?

- How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Peptic Ulcer?

- What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, licensing activities related to the Peptic Ulcer therapeutics?

- What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?

- What are the clinical studies going on for Peptic Ulcer and their status?

- What are the key designations that have been granted to the emerging drugs?

Key Players

- Daewoong Pharmaceutical

- HK inno.N Corporation

- PharmaKing

- Recce Pharmaceuticals

- Sequella Inc

- Shandong Luoxin Pharmaceutical

- RaQualia Pharma

- Sihuan Pharmaceutical Holdings Group

- Sinil Pharmaceutical

Key Products

- Fexuprazan

- Tegoprazan

- PMK S005

- R435

- SQ109

- Anaprazole

- SI-001002

Peptic Ulcer - Pipeline Insight, 2021

Table of Contents

Introduction
Executive Summary
Peptic Ulcer: Overview
* Causes
* Mechanism of Action
* Signs and Symptoms
* Diagnosis
* Disease Management
Pipeline Therapeutics
* Comparative Analysis
Therapeutic Assessment
* Assessment by Product Type
* Assessment by Stage and Product Type
* Assessment by Route of Administration
* Assessment by Stage and Route of Administration
* Assessment by Molecule Type
* Assessment by Stage and Molecule Type
Peptic Ulcer - DelveInsight's Analytical Perspective
In-depth Commercial Assessment
* Peptic Ulcer companies' collaborations, Licensing, Acquisition -Deal Value Trends
Peptic Ulcer Collaboration Deals
* Company-Company Collaborations (Licensing / Partnering) Analysis
* Company-University Collaborations (Licensing / Partnering) Analysis
Late Stage Products (Phase III)
* Comparative Analysis
Fexuprazan: Daewoong Pharmaceutical
* Product Description
* Research and Development
* Product Development Activities
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
* Comparative Analysis
PMK S005: PharmaKing
* Product Description
* Research and Development
* Product Development Activities
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
* Comparative Analysis
KFP H009: Jiangsu Carephar Pharmaceutical
* Product Description
* Research and Development
* Product Development Activities
Drug profiles in the detailed report…..

Inactive Products
* Comparative Analysis
Peptic Ulcer Key Companies
Peptic Ulcer Key Products
Peptic Ulcer- Unmet Needs
Peptic Ulcer- Market Drivers and Barriers
Peptic Ulcer- Future Perspectives and Conclusion
Peptic Ulcer Analyst Views
Peptic Ulcer Key Companies
Appendix

List of Tables

Table 1 Total Products for Peptic Ulcer
Table 2 Late Stage Products
Table 3 Mid Stage Products
Table 4 Early Stage Products
Table 5 Pre-clinical & Discovery Stage Products
Table 6 Assessment by Product Type
Table 7 Assessment by Stage and Product Type
Table 8 Assessment by Route of Administration
Table 9 Assessment by Stage and Route of Administration
Table 10 Assessment by Molecule Type
Table 11 Assessment by Stage and Molecule Type
Table 12 Inactive Products

List of Figures

Figure 1 Total Products for Peptic Ulcer
Figure 2 Late Stage Products
Figure 3 Mid Stage Products
Figure 4 Early Stage Products
Figure 5 Preclinical and Discovery Stage Products
Figure 6 Assessment by Product Type
Figure 7 Assessment by Stage and Product Type
Figure 8 Assessment by Route of Administration
Figure 9 Assessment by Stage and Route of Administration
Figure 10 Assessment by Molecule Type
Figure 11 Assessment by Stage and Molecule Type
Figure 12 Inactive Products
  • China Drugs for Traveler's Diarrhea Market Report & Forecast 2021-2027
    Published: 22-Oct-2021        Price: US 3400 Onwards        Pages: 90
    China Drugs for Traveler's Diarrhea Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Drugs for Traveler's Diarrhea Market Segment Percentages, By Type, 2020 (%) - Anti-motility agents - Bismuth Subsalicylate (Pepto-Bismol) - Antibiotics China Drugs for Traveler's Diarrhea Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Drugs for Traveler's Diarrhea Market Segment Percentages, By Application, 2020 (%)......
  • Global Gastroparesis Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 21-Oct-2021        Price: US 3480 Onwards        Pages: 90
    The Gastroparesis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest res......
  • Peptic Ulcer - Pipeline Insight, 2021
    Published: 12-Oct-2021        Price: US 1500 Onwards        Pages: 60
    DelveInsight's, "Peptic Ulcer - Pipeline Insight, 2021," report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Peptic Ulcer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered - Global coverage......
  • Global Anti-Peptic Ulcer Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 08-Oct-2021        Price: US 3480 Onwards        Pages: 93
    The Anti-Peptic Ulcer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest......
  • United States Drugs for Traveler's Diarrhea Market Report & Forecast 2021-2027
    Published: 05-Oct-2021        Price: US 3400 Onwards        Pages: 92
    United States Drugs for Traveler's Diarrhea Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) United States Drugs for Traveler's Diarrhea Market Segment Percentages, By Type, 2020 (%) - Anti-motility agents - Bismuth Subsalicylate (Pepto-Bismol) - Antibiotics United States Drugs for Traveler's Diarrhea Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) United States Drugs for Traveler's Diarrhea Market Segment Percenta......
  • Global and Japan Laxatives Market Insights, Forecast to 2027
    Published: 01-Oct-2021        Price: US 3900 Onwards        Pages: 134
    Laxatives market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Laxatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Laxatives market size by players, by ......
  • Global Gastrointestinal Partnering 2014-2021: Deal trends, players and financials
    Published: 01-Oct-2021        Price: US 3495 Onwards        Pages: 350
    Global Gastrointestinal Partnering 2014 to 2021 provides the full collection of Gastrointestinal disease deals signed between the world's pharmaceutical and biotechnology companies since 2014. Trends in Gastrointestinal partnering deals Financial deal terms for headline, upfront and royalty by stage of development Gastrointestinal partnering agreement structure Gastrointestinal partnering contract documents Top Gastrointestinal deals by value Mos......
  • Gastritis (Gastrointestinal) - Drugs in Development, 2021
    Published: 30-Sep-2021        Price: US 2000 Onwards        Pages: 99
    Gastritis (Gastrointestinal) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastritis - Drugs In Development, 2021, provides an overview of the Gastritis (Gastrointestinal) pipeline landscape.Gastritis is characterized by inflammation or swelling of the lining of the stomach. Acute gastritis lasts for a short period of time while chronic gastritis lasts for a long period of time (months to years).......
  • Systemic Mastocytosis (Gastrointestinal) - Drugs in Development, 2021
    Published: 30-Sep-2021        Price: US 2000 Onwards        Pages: 212
    Systemic Mastocytosis (Gastrointestinal) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Mastocytosis - Drugs In Development, 2021, provides an overview of the Systemic Mastocytosis (Gastrointestinal) pipeline landscape.Systemic mastocytosis is a disorder where mast cells are abnormally increased in multiple organs including the bone marrow. Symptoms include shortness of breath, low blood ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs